Safety evaluation of long-term ingestion of D-allulose in borderline diabates and type 2 diabetes.
- Conditions
- Borderline diabetes, type 2 diabetes
- Registration Number
- JPRN-UMIN000036394
- Lead Sponsor
- Rare Sugar Foods LLC
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 20
Not provided
(1)daily intake of dietary supplement related to blood glucose (2)serious damage to the liver, the renal, the heart, the lung, endocrine systems and metabolic functions (3)currently taking medications excluding diabetes patients (4)heavy user of alcohol and extremely random dietary habit (5)allergy to foods and medicines (6)abnormal values in the screening examination judged by the principal doctor (7)pregnancy, breastfeeding, or expected / planned pregnancy (8)participation in another clinical study (9)blood donation within 12 weeks of the screening examination (> 400 mL) or 4weeks (> 200 mL), or directed donation within 2 weeks of the screening examination (10)anyone judged as ineligible to participate in this study by the principal physician
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Occurrence, types, magnitude and frequency of the adverse event(including clinical examinations)
- Secondary Outcome Measures
Name Time Method